Tag: Pharmaceutical | Page 61 | NAI 500 | Page 61

- English
  - 简体中文
  - 繁體中文

Home
Pharmaceutical

Filter

Frontier Biotech

Nanjing Frontier Biotech Plans $285 Million IPO on Shanghai STAR Exchange

Aug 15, 2019

Sunniva Inc (CSE:SNN) Cannabis

Sunniva Provides Update On California Operations

Aug 14, 2019

DelMar

DelMar Reports Positive Phase II Data from China Trial of GBM Treatment

Aug 14, 2019

Chipscreen

Chipscreen Bio Climbs 367% on First Trading Day following Shanghai IPO

Aug 14, 2019

CStone

CStone Starts China Arm of Global RET Inhibitor Phase I Trial

Aug 14, 2019

Aslan

Aslan Presents Progress Update on its Three Clinical Candidates

Aug 14, 2019

Qiyu

Qiyu Biotech of Shanghai Completes A Funding Round for Novel Biologics

Aug 14, 2019

Bio-Thera

Bio-Thera Starts China Trials of a Third Arthritis Biosimilar

Aug 14, 2019

Ligand

Ligand Partner CASI Pharmaceuticals Launches EVOMELA® in China

Aug 13, 2019

Ascletis

Ascletis Opens Clinical Development Shanghai Center

Aug 13, 2019

Vapo Health

Vapo Health Completes Series A Round for Medical Device Business

Aug 12, 2019

AstraZeneca

AstraZeneca’s Tagrisso helps lung cancer patients live longer: study

Aug 10, 2019

Endologix

Endologix Announces Exclusive Distributor Agreement with Boston Scientific for the Chinese Market

Aug 10, 2019

Gilead Sciences

Gilead Approved to Bring New Three-Drug HIV Treatment to China

Aug 10, 2019

Gates Foundation

Gates Foundation snaps up top Apple Health researcher to run a new digital health group

Aug 10, 2019

Life Science, Technology

Nanjing King-Friend

Nanjing King-Friend Acquires Majority Stake in US Generic Injectables Company for $95 Million

Aug 9, 2019

PackGene

PackGene, a Viral Vector/CRISPR company, Completes Venture Round

Aug 8, 2019

CStone Pharma

CStone to Build Major R&D and Manufacturing Complex in Suzhou Park

Aug 8, 2019